3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
3
Completed
2
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
36
Plasma cell
24
Other hematologic neoplasm
7
Myeloid
3
Gastrointestinal
2
Dermatologic
2
Tumor-Agnostic
1
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Head & Neck
1
CNS
1
Conditions
Head and Neck Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Carboplatin
133
Cisplatin
130
Pemetrexed
114
Docetaxel
79
Drug Therapy
61
Gefitinib
57
anlotinib
55
Gemcitabine
55
Erlotinib Hydrochloride
55
Radiotherapy
48
Bevacizumab
48
pembrolizumab
47
Paclitaxel
47
Etoposide
44
apatinib
42
icotinib
41
camrelizumab
39
osimertinib
35
Vinorelbine
31
Nivolumab
31
Radiosurgery
30
sintilimab
29
aumolertinib
25
endostar protein
24
durvalumab
24
atezolizumab
23
Endostatins
22
Blood Specimen Collection
19
toripalimab
18
Immune Checkpoint Inhibitors
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Lenalidomide
×
Thoracic
×
Clear all
NCT01166035
2010-07-20
TEXO
Medical University Innsbruck
Phase 1/2
Unknown
20 enrolled